Jaguar Health Inc (NAS:JAGX)
$ 1.04 0 (0%) Market Cap: 9.61 Mil Enterprise Value: 27.72 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 35/100

Jaguar Health Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript

May 18, 2023 / 01:00PM GMT
Release Date Price: $40.79 (-0.01%)
Robert Blum
Lytham Partners - Managing Partner

All right, hello everyone, and thank you all for joining us during the Lytham Partners Spring 2023 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners, and during this webcast we welcome Jaguar Health, ticker symbol of JAGX on the Nasdaq, and their CEO, Lisa Conte. Today I've asked Lisa to run through the company slide presentation, and if time permits, we'll engage in a short question-and-answer session at the end there.

Before I do turn it over, I want to remind everyone that management is available for one-on-one meetings later today. If you've not already signed up and would like to do so, you can send me an email at [email protected], or visit the website, lythampartners.com/virtual, click on the one-on-one meeting request button, and we will look to get you taken care of there.

So, with that said, Lisa, let me turn the floor over to you to start walking through the presentation there.

Lisa Conte
Jaguar Health, Inc. - Founder, President & CEO

Thank

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot